Evidence map›Paper›PMID 41986433›Full record

ArticleCommunications medicine2026

System-level clustering of testosterone-related biomarkers identifies high-risk aging profiles linked to inflammation and renal function.

Nobuo Okui, Shigeo Horie

Abstract read
In one paragraph

Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nobuo OkuiInnovative Longevity, Juntendo University, Bunkyo, Tokyo, Japan. okuinobuo@gmail.com.ORCID http://orcid.org/0000-0001-5894-5283
Shigeo HorieInnovative Longevity, Juntendo University, Bunkyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerum total testosterone (TT) interacts with multiple physiological systems and is implicated in heterogeneous aging processes in men. However, aging-related phenotypes associated with TT are unlikely to be captured by single biomarkers or conventional clinical categories. This study aims to identify data-driven aging phenotypes based on TT and related clinical biomarkers using an unsupervised analytical framework.

methodsClinical laboratory data from 5,877 Japanese male patients undergoing routine health evaluations are analyzed. After restricting the cohort to individuals with complete age and body mass index data, missing values in other variables are imputed using column-wise mean imputation. Unsupervised clustering is performed using K-means on standardized biomarkers related to endocrine, metabolic, inflammatory, and renal function. Principal component analysis and correlation network analysis are used for visualization. External validation uses cancer prevalence data from the NHANES dataset.

resultsFour physiological clusters are identified. One cluster shows low TT levels, elevated inflammatory markers, impaired renal function, and higher cancer prevalence in external validation, indicating a high-risk aging profile. Other clusters show preserved hormonal and metabolic profiles. Network analysis reveals cluster-specific differences in the centrality of TT within physiological networks. Principal component analysis shows overlapping cluster distributions, reflecting continuous aging-related variation.

conclusionsUnsupervised clustering of TT-related biomarkers reveals aging phenotypes beyond conventional clinical classifications. TT functions as part of an integrated physiological network rather than as an isolated marker. These findings support a systems-level perspective on male aging and demonstrate utility of data-driven phenotyping, while acknowledging the descriptive and cross-sectional nature of the analysis.

Identifiers

PMID41986433
PMCPMC13083999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.